Hello, we’re Neuropad®
We help your feet stay healthy through early screening for diabetic foot syndrome and clinically proven treatment.
Test for diabetic foot issues with our screening test and protect against cracking with our foot foam, especially formulated for people with diabetes.
Why Neuropad®?
Diabetic foot ulcers and amputations are serious complications of poorly controlled diabetes, often caused by peripheral neuropathy — a condition that affects about half of all people with diabetes.
Worryingly, according to Diabetes UK, over 30% of people with diabetes aren’t even aware that foot problems are a common complication.
The Neuropad® 10-Minute Screening Test® can help in the early identification of diabetes-related foot problems.
Effectiveness of the Neuropad® 10-Minute Screening Test highlighted at the Neurodiab 2025 Annual Meeting
An important new ‘real-world’ NHS primary care study to assess the effectiveness of the Neuropad® 10-Minute Screening Test for early signs of peripheral neuropathy was presented at the 35th Annual Neurodiab meeting held from 11th to 14th September 2025 in Bucharest.
The study and the presentation highlight the effectiveness of the Neuropad® 10-Minute Screening Test at detecting early signs of diabetic peripheral neuropathy (DPN).
Where to get Neuropad®
You can buy Neuropad® 10-Minute Screening Test® and Neuropad® Foot Foam from our online store.
An introduction to Neuropad® for people with diabetes
How the 10-Minute Neuropad® Screening Test works
How to use and apply a Neuropad®
An introduction to Neuropad® for healthcare professionals
Latest news and updates
How weight loss could transform diabetes treatment
High Diagnostic Performance of the Indicator Plaster Neuropad for the Detection of Established Diabetic Autonomic Neuropathy
New Barbie doll with type 1 diabetes
Why is neuropathic pain worse at night?
Diabetes UK publishes response to the Government’s 10-year plan
Dutch study reveals that lab-grown cells may provide a potential cure for severe type 1 diabetes.
Doctors are now permitted to prescribe weight loss injections, but only within specific guidelines.
Groundbreaking research on diabetic neuropathy and nageotte nodules
International Diabetes Federation officially recognises “type 5 diabetes”
